María F Galindo (Mf Galindo, Maria Galindo)

Years Active: 2020-2023
Publications (10 Years): 6

Universidad de Castilla-La Mancha

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Castilla-La Mancha

Spain

Profesor Asociado :: Departamento de Ciencias Médicas

Publications

Ana Gómez-Martín, Jose Manuel Fuentes, Joaquin Jordán, María F Galindo, José Luis Fernández-García
Comparative Genetic Analysis of the Promoters of the ATG16L1 and ATG5 Genes Associated with Sporadic Parkinson's Disease. Genes 14 (12) (2023)
Ana Gómez-Martín, Jose Manuel Fuentes, Joaquin Jordán, María F Galindo, José Luis Fernández-García
Comparative Genetic Analysis of the Promoters of the ATG16L1 and ATG5 Genes Associated with Sporadic Parkinson's Disease. Genes 14 (12) (2023)
Ana Gómez-Martín, Jose Manuel Fuentes, Joaquin Jordán, María F Galindo, José Luis Fernández-García
Comparative Genetic Analysis of the Promoters of the ATG16L1 and ATG5 Genes Associated with Sporadic Parkinson's Disease. Genes 14 (12) (2023)
Ana Gómez-Martín, Jose Manuel Fuentes, Joaquin Jordán, María F Galindo, José Luis Fernández-García
Comparative Genetic Analysis of the Promoters of the ATG16L1 and ATG5 Genes Associated with Sporadic Parkinson's Disease. Genes 14 (12) (2023)
N Monteagudo-Martínez, Julian Solis García Del Pozo, Ichiro Ikuta, María F Galindo, Joaquin Jordán
Systematic review and meta-analysis on the safety of dalbavancin. Expert opinion on drug safety 20 (9) (2021)
Nuria Monteagudo-Martínez, Julian Solis García Del Pozo, Eduardo Nava, Ichiro Ikuta, María F Galindo, Joaquin Jordán
Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis. Expert review of anti-infective therapy (2020)

María F Galindo.css-eqlu8i{font-size:small;padding-left:4px;} (Mf Galindo, Maria Galindo)